Dynamic Risk Modelling of Hepatocellular Carcinoma
Liver International · 2026-05 · 46 (5)
DOI: 10.1111/liv.70636 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 12.04.2026. Verfasst von Zhenning Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Despite advancements in the detection and treatment of hepatocellular carcinoma (HCC), the overall survival remains poor. Traditional survival analyses, such as the Cox model, are limited in capturing the dynamic progression across different clinical states. Our paper proposes the utilization of a continuous‐time multi‐state Markov model to inform risk stratification and management strategies for HCC by accounting for transitions between disease states.
Methods
This cohort study included 934 adult patients (25.0% female) with HCC who underwent curative treatment, defined as liver transplantation, resection or ablation, across eight tertiary centres in Australia, China, Japan, Singapore, South Korea and the United States. The primary objective was to assess the risk of HCC recurrence and survival following curative treatment.
Results
The median (IQR) age of the cohort was 65 (IQR 58–74), and 72% had known cirrhosis. Distinct clinical trajectories were identified: recurrence, death without recurrence and death after recurrence. The median (IQR) time from curative treatment to recurrence, from recurrence to death, and from curative treatment to death without recurrence was 15.40 months (4.78–26.01), 51.27 months (20.04–82.50), and 23.13 months (9.26–37.01), respectively. Analyses revealed that advancing age and HCV were associated with recurrence risk, while liver transplantation was protective against recurrence. Ablation, non‐curative locoregional therapy, and systemic therapies were associated with higher risks of recurrence and post‐recurrence death. Alpha‐fetoprotein, tumour size, INR, bilirubin and advanced BCLC stage were key predictors of recurrence and mortality.
Conclusion
By modelling disease as a sequence of interlinked transitions, we provide updated estimates for the time spent within each transition state and predictors for disease progression within a dynamic framework.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- National University Centre for Digestive Health, National University Hospital, Singapore.
- A.W. Morrow Gastroenterology and Liver Centre, Australian Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
- Division of Gastroenand Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA.
ORCID-Profile: Zhenning Yu, Ken Liu, Sung Won Lee, Gang Chen, Takumi Kawaguchi, Hirokazu Takahashi, Daniel Q Huang
Zitieren
APA
Yu, Z., Gunalan, S. Z., Tang, N. S. Y., Liu, K., Wijarnpreecha, K., Kim, B. K., Lee, S. W., Muthiah, M. D., Chen, G., Kawaguchi, T., Takahashi, H., Huang, D. Q., & Liver Cancer Research Network (2026). Dynamic Risk Modelling of Hepatocellular Carcinoma. Liver International, 46(5). https://doi.org/10.1111/liv.70636
Vancouver
Yu Z, Gunalan SZ, Tang NSY, Liu K, Wijarnpreecha K, Kim BK, et al. Dynamic Risk Modelling of Hepatocellular Carcinoma. Liver International. 2026;46(5). doi:10.1111/liv.70636
BibTeX
@article{Yu2026,
author = {Yu, Zhenning and Gunalan, Shyna Zhuoying and Tang, Nicole Shu Ying and Liu, Ken and Wijarnpreecha, Karn and Kim, Beom Kyung and Lee, Sung Won and Muthiah, Mark D and Chen, Gang and Kawaguchi, Takumi and Takahashi, Hirokazu and Huang, Daniel Q and Liver Cancer Research Network, Liver Cancer Research Network},
title = {Dynamic Risk Modelling of Hepatocellular Carcinoma},
journal = {Liver International},
year = {2026},
volume = {46},
number = {5},
doi = {10.1111/liv.70636}
}
EUVIMED